Skip to Content

CDD for Biologics Summit Boston 2017

Start Date:
Tuesday, 5 December, 2017
End Date:
Thursday, 7 December, 2017 6:00pm
Internal Medicine

Biologic-based therapeutics have continued to become more complex both by modality and delivery. Much like the small molecule arena, computational tools are being sought to streamline drug design, development and manufacture. The 2nd Annual Computational Drug Development (CDD) for Biologics Summit is dedicated to exploring the application of in-silico tools within the development paradigm for biologics. Designed with input from thought leaders at organizations such as Genentech, Bristol-Myers Squibb, AbbVie, EMD Serono and Novartis, identify how to streamline your early drug discovery pipeline, enhance developability and improve the success rate of lead biologic candidates. * Please note: We also offer a start-up rate for small biotech organisations, as well as academic discounts.

For more information and to check eligibility criteria, please visit the website. * URL: Brochure: Price: Register By 6 October: Conference and Workshop: USD 2998, Register By 6 October: Conference Only: USD 2499, Standard Rate: Conference and Workshop: USD 3198, Standard Rate: Conference Only: USD 2699, Workshop Only: USD 699 Speakers: Stanley Krystek (Bristol Myers-Squibb), Chris Roberts (University of Delaware), Vanita Sood (EMD Serono), Sarah Sirin (AbbVie), Bernhardt L Trout (MIT)


Revere Hotel Boston Common,
200 Stuart Street,
United States

Organizer Details

Conference organized by Hanson Wade


Medical conference data provided by Meetings4Docs | Report a problem

Image Gallery